A study of the microbiology of diabetic foot infections in a teaching hospital in Kuwait.

The purpose of this study was to determine the microbiological profile of diabetic foot infections (DFIs) and assess the antibiotic susceptibility of the causative agents. Data were obtained from a retrospective analysis of DFI samples collected from June 2007 to July 2008. Specimens were cultured using optimal aerobic and anaerobic microbiological techniques, and antibiotic susceptibility testing was performed according to the methods recommended by the Clinical and Laboratory Standards Institute (CLSI). Extended-spectrum β-lactamase (ESBL) production was measured using the double disk synergy test and the ESBL Etest. A total of 440 patients were diagnosed with DFIs during this period, and a total of 777 pathogens were isolated from these patients with an average of 1.8 pathogens per lesion. We isolated more Gram-negative pathogens (51.2%) than Gram-positive pathogens (32.3%) or anaerobes (15.3%). Polymicrobial infection was identified in 75% of the patients. The predominant organisms isolated were members of the Enterobacteriaceae family (28.5%), Pseudomonas aeruginosa (17.4%), Staphylococcus aureus (11.8%), methicillin-resistant S. aureus (7.7%), anaerobic Gram-negative organisms (10.8%), and Enterococcus spp. (7%). Vancomycin was the most effective treatment for Gram-positive bacteria, and imipenem, piperacillin-tazobactam and amikacin were the most effective treatments for the Gram-negative bacteria. In conclusion, DFI is common among diabetic patients in Kuwait, and most of the cases evaluated in this study displayed polymicrobial etiology. The majority of isolates were multi-drug resistant. The data gathered in this study will be beneficial for future determinations of empirical therapy policies for the management of DFIs.

[1]  Benjamin A Lipsky,et al.  Bacteriology of Moderate-to-Severe Diabetic Foot Infections and In Vitro Activity of Antimicrobial Agents , 2007, Journal of Clinical Microbiology.

[2]  E. Goldstein,et al.  Clostridium aldenense sp. nov. and Clostridium citroniae sp. nov. Isolated from Human Clinical Infections , 2006, Journal of Clinical Microbiology.

[3]  W. Jeffcoate,et al.  Diabetic foot ulcers , 2003, The Lancet.

[4]  N. Abdella,et al.  Prevalence of Type 2 Diabetes Mellitus among Kuwaiti Children and Adolescents , 2008, Medical Principles and Practice.

[5]  Benjamin A Lipsky,et al.  Diagnosis and treatment of diabetic foot infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  A. Zaini Where is Malaysia in the midst of the Asian epidemic of diabetes mellitus? , 2000, Diabetes research and clinical practice.

[7]  R. Frykberg An evidence-based approach to diabetic foot infections. , 2003, American journal of surgery.

[8]  E H Wagner,et al.  Incidence, outcomes, and cost of foot ulcers in patients with diabetes. , 1999, Diabetes care.

[9]  E. Goldstein,et al.  Diabetic Foot Infections: Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases , 1996, Diabetes Care.

[10]  U. Pennsylvania,et al.  Clinical and Laboratory Standards Institute , 2019, Springer Reference Medizin.

[11]  R. Hill,et al.  Infection of foot ulcers with Staphylococcus aureus associated with increased mortality in diabetic patients. , 2000, Communicable disease and public health.

[12]  Benjamin A Lipsky A report from the international consensus on diagnosing and treating the infected diabetic foot , 2004, Diabetes/metabolism research and reviews.

[13]  Z. Bitar,et al.  Bacteriological study of diabetic foot infections. , 2005, Journal of diabetes and its complications.

[14]  A. Edo,et al.  Bacteriology of diabetic foot ulcers in Benin City, Nigeria , 2007 .